Cited by

• Orogenital Human Papillomavirus Infection and Vaccines: A Survey of High- and Low-Risk Genotypes Not Included in Vaccines.

  Buttà M, Serra N, Panzarella V, Fasciana TMA, Campisi G, Capra G. Buttà M, et al. Vaccines (Basel). 2023 Sep 7;11(9):1466. doi: 10.3390/vaccines11091466. Vaccines (Basel). 2023. PMID: 37766142 Free PMC article.
• Oral HPV Infection in Women with HPV-Positive Cervix Is Closely Related to Oral Sex.

  Bruno MT, Boemi S, Caruso G, Sgalambro F, Ferlito S, Cavallaro A, Sudano MC, Palumbo M. Bruno MT, et al. Diagnostics (Basel). 2023 Jun 16;13(12):2096. doi: 10.3390/diagnostics13122096. Diagnostics (Basel). 2023. PMID: 37370992 Free PMC article.
• A clinician's dilemma: what should be communicated to women with oncogenic genital HPV and their partners regarding the risk of oral viral transmission?

  Monti E, Barbara G, Libutti G, Boero V, Parazzini F, Ciavattini A, Bogani G, Pignataro L, Magni B, Merli CEM, Vercellini P. Monti E, et al. BMC Womens Health. 2022 Sep 17;22(1):379. doi: 10.1186/s12905-022-01965-x. BMC Womens Health. 2022. PMID: 36115987 Free PMC article.
• Human papillomaviruses: diversity, infection and host interactions.

  McBride AA. McBride AA. Nat Rev Microbiol. 2022 Feb;20(2):95-108. doi: 10.1038/s41579-021-00617-5. Epub 2021 Sep 14. Nat Rev Microbiol. 2022. PMID: 34522050 Review.
• High prevalence of human papillomavirus and European variants of HPV 16 infecting concomitantly to cervix and oral cavity in HIV positive women.

  Pérez-Quintanilla M, Méndez-Martínez R, Vázquez-Vega S, Espinosa-Romero R, Sotelo-Regil R, Pérez-Montiel MD, Ramos-Alamillo U, Cabrera-López TJ, Barquet-Muñoz SA, Pérez-Plascencia C, García-Carrancá A, Cantú de León D. Pérez-Quintanilla M, et al. PLoS One. 2020 Apr 22;15(4):e0227900. doi: 10.1371/journal.pone.0227900. eCollection 2020. PLoS One. 2020. PMID: 32320400 Free PMC article.